Hypoactive sexual desire disorder: Inventing a disease to sell low libido

Journal of Medical Ethics

Volumn 41, Issue 10, 2015, Pages 859-862

  Meixel, Antonie ^a   Yanchar, Elena ^a   Fugh Berman, Adriane ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BENZIMIDAZOLE DERIVATIVE; FLIBANSERIN;

DRUG APPROVAL; DRUG EFFECTS; DRUG INDUSTRY; ETHICS; FEMALE; FOOD AND DRUG ADMINISTRATION; HUMAN; LIBIDO; MALE; MEDICAL EDUCATION; QUALITY OF LIFE; SELF REPORT; SEXUAL BEHAVIOR; SEXUAL DYSFUNCTIONS, PSYCHOLOGICAL; SOCIAL MARKETING; UNITED STATES;

BENZIMIDAZOLES; DRUG APPROVAL; DRUG INDUSTRY; EDUCATION, MEDICAL, CONTINUING; FEMALE; HUMANS; LIBIDO; MALE; QUALITY OF LIFE; SELF REPORT; SEXUAL BEHAVIOR; SEXUAL DYSFUNCTIONS, PSYCHOLOGICAL; SOCIAL MARKETING; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION;

EID: 84942252385     PISSN: 03066800     EISSN: 14734257     Source Type: Journal    
DOI: 10.1136/medethics-2014-102596     Document Type: Article

References (36)

1. Angelmar R, Angelmar S, Kane L. Building strong condition brands. J Med Mark 2007;(7):341-51.
2. Parry V. The art of branding a condition. Med Mark Media 2003;38(5):43-6.
3. Deer B. Sex drugs&rock'n' roll. The Sunday Times Magazine 6 Sept 1998. http://briandeer.com/pfizer-viagra-1.htm
4. Lexchin J. Bigger and better: how Pfizer redefined erectile dysfunction. PLoS Med 2006;3(4):e132.
5. Moynihan R. The making of a disease: female sexual dysfunction. BMJ 2003;326:45-7.
6. Tiefer L. Female sexual dysfunction: a case study of disease mongering and activist resistance. PLoS Med 2006;3(4):178.
7. Moynihan R. The marketing of a disease: female sexual dysfunction. BMJ 2005;330(7484):192-4.
8. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th edn. Washington DC: American Psychiatric Press, 2000.
9. IsHak WW, Tobia G. DSM-5 Changes in Diagnostic Criteria of Sexual Dysfunctions. Reprod Sys Sex Dis 2013;2:122.
10. Grogan K. Sprout resubmits 'female Viagra' to FDA. Pharma Times, 27 Jun 2013. http://www.pharmatimes.com/Article/13-06-27/Sprout_resubmits_female_Viagra_ to_FDA.aspx
11. Thacker P. How to Handle FDA Rejection. Slate, 6 Apr 2014. http://www.slate.com/articles/double_x/doublex/2014/04/female_viagra_and_the_fda_the_agency_s_ rejection_of_flibanserin_has_nothing.html
12. Fugh-Berman A, Melnick D. Off-label promotion, on-target sales. PLoS Med 2008;5(10):210.
13. Moynihan R. Merging of marketing and medical science: female sexual dysfunction. BMJ 2010;341:c5050.
14. Moynihan R, Mintzes B. Sex, lies, and pharmaceuticals: how drug companies plan to profit from female sexual dysfunction. Sydney, Australia: Allen and Unwin Pty Ltd., 2010.
15. Wysocki S, Kellogg-Spadt S, Kingsberg SA, et al. Talking to Female Patients about Sexual Health: Overcoming Common Communication Challenges. Medscape. Released: 25 May 2010. Expires 25 May 2011. http://cme.medscape.com/viewarticle/721398 (accessed 17 Aug 2013).
16. Bachmann GA, Kellogg-Spadt S. Communication Strategies in Assessing Sexual Health: The Short Interview-Uncovering the need for a Long interview. Medscape and the University of Medicine&Dentistry of New Jersey. Released 3 Feb 2010. Expires 3 Feb 2011. http://cme.medscape.com/viewarticle/713409 (accessed 17 Aug 2013).
17. Bailey LA, Krychman ML. Communication Strategies in Assessing Sexual Health: Uncovering an Underlying Condition. Medscape and the University of Medicine & Dentistry of New Jersey. Released 11 Feb 2010. Expires 11 Feb 2011. http://cme. medscape.com/viewarticle/712564 (accessed 17 Aug 2013).
18. Kingsberg SA, Kellogg-Spadt S. The Essentials of Assessing the Sexual Concerns of Your Female Patients. Medscape and the University of Medicine&Dentistry of New Jersey. Released 2 Feb 2010. Expires 2 Feb 2011. http://cme.medscape.com/viewarticle/710343 (accessed 17 Aug 2013).
19. Green MA, Martinez LA. Female Sexual Dysfunction: Recognizing the Impact on Patient and Partner. Medscape. Released 21 May 2010. http://cme.medscape.com/viewarticle/721520 (accessed 17 Aug 2013).
20. Pillai-Friedman S. Barriers to Communication About Female Sexual Health: Tips for Successful Dialogue with Patients. Medscape. Released 21 May 2010. http://cme. medscape.com/viewarticle/721521 (accessed 17 Aug 2013).
21. Kingsberg SA (author), Bachmann GA ( peer-reviewer). Diagnosis and Classification of Female Sexual Dysfunction. Baylor College of Medicine. Released Aug 2008. Expires Aug 2010.
22. Kingsberg SA. Vaginismus and Hypoactive Sexual Desire Disorder in a Young Woman. Baylor College of Medicine. Released May 2009. Expired May 2010.
23. Kingsberg SA, Simon JA. Hypoactive sexual desire disorder in women: implications for family practice. SUPPL J Fam Pract 2009;58(7). Released 15 July 2009. Expires 15 July 2010.
24. Cox R, Moore LF. Empowering PAs to ask their female patients about sexual health. JAAPA 2010;23:19-21, 46.
25. Kingsberg SA, Altman AM, Parish SJ. Sexuality, assessment and treatment of hypoactive sexual desire disorder. Sex Reprod Menopause 2010;8(1). Online version released 1 Feb 2010. Expires 1 Feb 2011.
26. Clayton AH, Brotto L, Kingsberg SA, et al. The Science and Medicine of Hypoactive Sexual Desire Disorder (HSDD). The University of Massachusetts Medical School, Pharmatecture LLC, CMEducation Resources LLC. Released 18 May 2010. Expires 18 May 2012. http://www.clinicalwebcasts.com/cvr/117.htm (accessed 17 Aug 2013).
27. Levine SB. Hypoactive sexual desire disorder in women. Presentation at 22nd Annual U.S. Psychiatric and Mental Health Congress Conference and Exhibition 4 Nov 2009. (CME LLC).
28. Wysocki S. Women's Sexual Health, Addressing Low Libido. Released 3 May 2010. Expires 3 May 2012. CMEcorner.com.
29. Fugh-Berman A, Dodgson S. The ethics of publication planning in the pharmaceutical industry. Open Med 2008;4(5):40-3.
30. Laumann E, Paik A, Rosen R. Sexual dysfunction in the United States: prevalence and predictors. JAMA 1999;281(6);537-44.
31. Female Sexual Function Index. 2000. http://www.fsfi-questionnaire.com (accessed 17 Aug 2013).
32. Frühauf S, Gerger H, Schmidt HM, et al. Efficacy of psychological interventions for sexual dysfunction: a systematic review and meta-analysis. Arch Sex Behav 2013; 42(6):915-33.
33. Stadler T, Bader M, Ückert S, et al. Adverse effects of drug therapies on male and female sexual function. World J Urol 2006;24(6):623-9.
34. Live Meetings Sway MDs to Screen for HSDD. Physician's Weekly, 28 Jun 2012. http://www.physiciansweekly.com/female-sexual-disorder/
35. Omnia Education. Hypoactive sexual desire disorder: Assessment, diagnosis and treatments; Hypoactive sexual desire disorder: Issues and answers, fact and fiction; Hypoactive sexual desire disorder: Diagnosing and managing the most common female sexual dysfunction. ReachMD. http://www.omniaeducation.com/CME_ EventGroup.asp?eventGroupCode=737L7B14O24 (accessed 23 Aug 2014).
36. Scudellari M. That loving feeling. The Scientist, 1 Jul 2014. http://www.the-scientist. com/?articles.view/articleNo/40272/title/That-Loving-Feeling